What is CBG Biotech?
CBG Biotech is a prominent manufacturer and supplier specializing in solvent recovery and recycling systems. With over two decades of operational experience, the company provides tailored solutions for laboratory, industrial, and cannabis applications. Their commitment lies in delivering sustainable technologies that improve safety, boost efficiency, and increase profitability for clients. The product portfolio includes a range of solvent recyclers, HAP-free solvents, and extraction systems, all designed to assist businesses in achieving their sustainability objectives while reducing solvent-related expenditures.
How much funding has CBG Biotech raised?
CBG Biotech has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in CBG Biotech
PPP
Public-Private Partnership
What's next for CBG Biotech?
The substantial large-scale late-stage funding indicates CBG Biotech is poised for significant expansion and market penetration. This capital infusion is likely to fuel advancements in their sustainable technology offerings, potentially broadening their product lines or enhancing existing systems. Strategic investments at this stage often signal a focus on scaling operations, increasing market share, and possibly exploring new industry verticals or geographical markets. The company's continued emphasis on efficiency and profitability suggests a strategic direction aimed at solidifying its leadership in the environmental solutions sector.
See full CBG Biotech company page
